GO:1903298 negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903298 describes any process that stops, prevents or reduces the frequency, rate or extent of the hypoxia-induced intrinsic apoptotic signaling pathway.
• Hypoxia-induced apoptosis critically involves the mitochondrial (intrinsic) death pathway in a FADD/caspase-8 independent manner.
• The term is a biological_process ontology annotation used to capture protective or anti-apoptotic mechanisms under low oxygen conditions.
• Key molecular players include BCL-2 family proteins, caspases, and hypoxia-inducible factors that modulate mitochondrial outer membrane permeabilization.
• Dysregulation of this process contributes to cancer progression, ischemic injury, and neurodegenerative disorders.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect the causal roles of genes in this pathway.
Description
GO:1903298, negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway, is a Gene Ontology biological process term that defines any mechanism capable of stopping, preventing, or reducing the frequency, rate, or extent of the intrinsic apoptotic signaling pathway triggered by hypoxia. Hypoxia, or low oxygen availability, is a common stress condition in solid tumors, ischemic tissues, and inflamed microenvironments, and it can activate the mitochondrial apoptotic cascade. Understanding how cells negatively regulate this pathway is fundamental for identifying therapeutic targets that either promote cell survival in ischemic diseases or induce cell death in hypoxic tumors. The intrinsic apoptotic pathway, also known as the mitochondrial death pathway, is critically involved in hypoxia-induced apoptosis and operates independently of the extrinsic FADD/caspase-8 axis. This article synthesizes the authoritative QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, genes, and experimental models relevant to GO:1903298.
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway At A Glance
| GO ID | GO:1903298 |
|---|---|
| GO term | negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway |
| Ontology | biological_process |
| Synonym | negative regulation of hypoxia-induced apoptosis; protection against hypoxia-induced apoptosis; downregulation of intrinsic apoptotic signaling pathway in response to hypoxia |
| Major function | Suppression of mitochondrial apoptotic signaling triggered by hypoxia |
| Definition source | QuickGO definition: Any process that stops, prevents or reduces the frequency, rate or extent of hypoxia-induced intrinsic apoptotic signaling pathway. |
| Related pathway | Intrinsic (mitochondrial) apoptotic pathway, FADD/caspase-8 independent |
| Biological context | Hypoxic stress, cancer, ischemia, neurodegeneration |
What Is GO:1903298?
In our own words, GO:1903298 encompasses any cellular process that inhibits, prevents, or diminishes the intrinsic apoptotic signaling pathway that is specifically initiated by hypoxia. This includes molecular events that stabilize mitochondrial integrity, reduce cytochrome c release, inhibit caspase activation, or modulate BCL-2 family protein interactions, all of which counteract the pro-apoptotic effects of low oxygen tension.
Why Is negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway Important in Cell Biology?
GO:1903298 is important because hypoxia is a central feature of many pathological conditions, including solid tumors, myocardial infarction, stroke, and chronic inflammatory diseases. The intrinsic apoptotic pathway is a major route to cell death under hypoxia, and its negative regulation can determine whether cells survive or die. In cancer, upregulation of negative regulators of this pathway promotes tumor cell survival and resistance to therapy, whereas in ischemic diseases, enhancing these negative regulators could protect tissues from hypoxia-induced damage. Therefore, understanding the molecular mechanisms that negatively regulate hypoxia-induced intrinsic apoptosis is critical for developing targeted therapeutic strategies.
• Hypoxia-induced intrinsic apoptosis is a key cell death mechanism in solid tumors, and its negative regulation contributes to tumor survival and chemoresistance.
• In ischemic heart disease and stroke, negative regulation of this pathway may protect cardiomyocytes and neurons from hypoxia-induced death.
• The intrinsic pathway operates independently of FADD/caspase-8, making it a distinct target for therapeutic intervention.
• BCL-2 family proteins are central regulators of mitochondrial outer membrane permeabilization and are frequently dysregulated in cancers.
• Hypoxia-inducible factors (HIFs) can transcriptionally modulate pro- and anti-apoptotic genes, influencing the balance of this pathway.
• CRISPR screens have identified negative regulators of hypoxia-induced apoptosis, offering new drug targets.
• Understanding this process aids in the development of cytoprotective strategies for ischemic diseases.
• It is relevant to neurodegenerative diseases where hypoxia contributes to neuronal loss.
• The term is used in functional enrichment analysis to interpret gene expression changes under hypoxia.
• It provides a framework for studying crosstalk between hypoxia signaling and apoptosis.
What Happens During negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway?
Hypoxia Sensing and Initiation of Intrinsic Apoptosis
In simple terms: When oxygen levels drop, cells sense the stress and can trigger a self-destruct program through mitochondria.
Hypoxia leads to mitochondrial dysfunction and activation of the intrinsic apoptotic pathway, which is critically involved in hypoxia-induced apoptosis in a FADD/caspase-8 independent manner. This initiation step involves changes in mitochondrial membrane potential and the release of pro-apoptotic factors.
Mitochondrial Outer Membrane Permeabilization (MOMP)
In simple terms: The mitochondria decide whether to leak death signals, and this decision is controlled by BCL-2 family proteins.
The intrinsic pathway is regulated by BCL-2 family proteins, which control mitochondrial outer membrane permeabilization (MOMP). Negative regulation of this pathway often involves anti-apoptotic BCL-2 proteins preventing MOMP and subsequent cytochrome c release.
Caspase Activation and Apoptosome Formation
In simple terms: Once death signals leak out, they activate a chain of enzymes called caspases that dismantle the cell.
Following MOMP, cytochrome c release leads to apoptosome formation and activation of caspase-9 and downstream effector caspases. Negative regulation of this pathway can occur through inhibitors of apoptosis (IAPs) or by preventing apoptosome assembly.
Negative Regulation by Anti-Apoptotic Signals
In simple terms: Survival signals can put brakes on the death machinery to keep cells alive under low oxygen.
Negative regulation of hypoxia-induced intrinsic apoptosis can be mediated by anti-apoptotic proteins such as BCL-2, BCL-xL, and MCL-1, which sequester pro-apoptotic BH3-only proteins. Additionally, hypoxia-inducible factors may transcriptionally upregulate anti-apoptotic genes to promote survival.
Key Genes Involved in GO:1903298 negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
The following genes and proteins are central to the negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BCL2 | Anti-apoptotic protein, inhibits MOMP | Overexpression protects against hypoxia-induced apoptosis |
| BCL2L1 (BCL-xL) | Anti-apoptotic, blocks cytochrome c release | Key negative regulator in cancer |
| MCL1 | Anti-apoptotic, sequesters BH3-only proteins | Promotes survival under hypoxia |
| BAX | Pro-apoptotic, promotes MOMP | Its inhibition enhances negative regulation |
| BAK1 | Pro-apoptotic, promotes MOMP | Its inhibition enhances negative regulation |
| CASP9 | Initiator caspase, activates downstream caspases | Its inhibition blocks intrinsic apoptosis |
| CASP3 | Executioner caspase | Its inhibition prevents apoptosis |
| CYCS | Cytochrome c, released from mitochondria | Its release is a key step in intrinsic apoptosis |
| APAF1 | Forms apoptosome with cytochrome c | Its inhibition blocks caspase activation |
| XIAP | Inhibitor of apoptosis, inhibits caspases | Negative regulator of apoptosis |
| HIF1A | Hypoxia-inducible factor, transcription factor | Regulates pro- and anti-apoptotic genes |
| TP53 | Tumor suppressor, can promote apoptosis | Its activity can counteract negative regulation |
| BID | BH3-only protein, links extrinsic and intrinsic pathways | Its inhibition may enhance negative regulation |
| PMAIP1 (NOXA) | BH3-only protein, promotes apoptosis | Its inhibition enhances negative regulation |
| BBC3 (PUMA) | BH3-only protein, promotes apoptosis | Its inhibition enhances negative regulation |
| AKT1 | Survival kinase, phosphorylates pro-apoptotic proteins | Promotes negative regulation |
| MAPK1 (ERK2) | Survival signaling kinase | Can promote negative regulation |
How Is negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway Regulated?
The negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway is itself regulated by upstream signaling cascades, including the PI3K/AKT pathway, which promotes cell survival by inhibiting pro-apoptotic proteins such as BAD and caspase-9. Additionally, hypoxia-inducible factors (HIFs) can transcriptionally upregulate anti-apoptotic BCL-2 family members, thereby enhancing negative regulation. The balance between pro- and anti-apoptotic BCL-2 family proteins is a critical determinant of whether cells survive or undergo apoptosis under hypoxia.
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BCL2 | Cancer, lymphoma | Overexpression in cancer cell lines under hypoxia |
| HIF1A | Cancer, ischemia | Knockout in hypoxic tumor models |
| CASP9 | Ischemia, neurodegeneration | Point mutation to inhibit caspase activity |
| MCL1 | Cancer, chemoresistance | Knock-in of degradation-resistant mutant |
| BAX | Cancer, apoptosis resistance | Knockout to prevent MOMP |
Cancer
In solid tumors, hypoxia is common and can induce intrinsic apoptosis. However, cancer cells often upregulate negative regulators of this pathway, such as BCL-2 or MCL-1, to survive hypoxic stress and resist chemotherapy. Targeting these negative regulators is a promising therapeutic strategy.
Ischemic Diseases
In myocardial infarction and stroke, hypoxia-induced intrinsic apoptosis contributes to tissue damage. Enhancing negative regulation of this pathway could protect cardiomyocytes and neurons from ischemic injury.
Neurodegenerative Disorders
Chronic hypoxia is implicated in neurodegenerative diseases such as Alzheimer's and Parkinson's, where neuronal apoptosis occurs. Modulating the negative regulation of hypoxia-induced intrinsic apoptosis may offer neuroprotective benefits.
From negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate hypoxia-induced intrinsic apoptosis? | CRISPR knockout of gene X in hypoxic cells |
| Does a specific point mutation in gene X affect its anti-apoptotic function? | CRISPR point mutation knock-in |
| Does overexpression of gene X protect against hypoxia-induced apoptosis? | CRISPR overexpression (CRISPRa) or lentiviral overexpression |
| Does tagging gene X with a fluorescent protein affect its localization under hypoxia? | CRISPR knock-in of tag |
| Which genes are essential for negative regulation of hypoxia-induced apoptosis? | Genome-wide CRISPR library screening |
| What is the transcriptional response to hypoxia in cells with gene X knockout? | RNA-seq and bioinformatics analysis |
How to Study the negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for negative regulation | Identify novel anti-apoptotic genes |
| RNA-seq | Transcriptional changes under hypoxia | Map gene expression networks |
| Proteomics | Protein abundance and interactions | Discover signaling complexes |
| Phosphoproteomics | Kinase signaling changes | Identify survival pathways |
| Live-cell imaging | Mitochondrial potential, caspase activity | Monitor apoptosis dynamics |
| Flow cytometry | Apoptosis quantification (Annexin V) | Validate negative regulation |
| Western blot | Protein cleavage (caspases, PARP) | Confirm apoptosis inhibition |
| Immunoprecipitation | Protein-protein interactions | Study BCL-2 family complexes |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes whose loss enhances or diminishes hypoxia-induced intrinsic apoptosis, revealing negative regulators.
RNA Sequencing (RNA-seq)
RNA-seq under hypoxia can quantify expression changes in anti-apoptotic and pro-apoptotic genes, helping to map the regulatory network.
Proteomics and Phosphoproteomics
Mass spectrometry-based proteomics can identify protein interactions and post-translational modifications that mediate negative regulation of the pathway.
Live-Cell Imaging
Fluorescent reporters for mitochondrial membrane potential and caspase activity allow real-time monitoring of apoptosis under hypoxia.
How CRISPR Can Be Used to Study GO:1903298 negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
Knockout
CRISPR knockout of candidate negative regulators (e.g., BCL2, MCL1) can sensitize cells to hypoxia-induced apoptosis, confirming their role in GO:1903298.
Point Mutation
Introducing point mutations in genes such as CASP9 or BAX can dissect specific domains required for their pro-apoptotic function and how negative regulators counteract them.
Knock-in
Knock-in of tagged versions of BCL-2 family proteins allows tracking their localization and interactions under hypoxia.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of anti-apoptotic genes can enhance negative regulation and protect cells from hypoxia-induced death.
How EDITGENE Supports negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway Research
Researchers studying negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway-related genes often need to determine whether a candidate gene is causally involved in this process. EDITGENE provides comprehensive CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway research.
Frequently Asked Questions About negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway
What is GO:1903298?
GO:1903298 is a Gene Ontology biological process term for any process that stops, prevents or reduces the frequency, rate or extent of hypoxia-induced intrinsic apoptotic signaling pathway.
What genes are involved in negative regulation of hypoxia-induced intrinsic apoptosis?
Key genes include BCL2, BCL2L1, MCL1, XIAP, and HIF1A, which act to inhibit mitochondrial outer membrane permeabilization and caspase activation.
How does hypoxia induce intrinsic apoptosis?
Hypoxia triggers mitochondrial dysfunction and activation of the intrinsic apoptotic pathway in a FADD/caspase-8 independent manner, leading to cytochrome c release and caspase activation.
What is the role of BCL-2 family proteins in this pathway?
BCL-2 family proteins control mitochondrial outer membrane permeabilization; anti-apoptotic members like BCL-2 and MCL-1 negatively regulate the pathway by preventing MOMP.
Which diseases are associated with dysregulation of this pathway?
Cancer, ischemic heart disease, stroke, and neurodegenerative disorders are associated with altered negative regulation of hypoxia-induced intrinsic apoptosis.
How can CRISPR be used to study GO:1903298?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of genes involved in this pathway.
What methods are used to measure negative regulation of hypoxia-induced apoptosis?
Common methods include flow cytometry with Annexin V, caspase activity assays, live-cell imaging of mitochondrial potential, and Western blot for caspase cleavage.
What is the difference between intrinsic and extrinsic apoptosis?
The intrinsic pathway is mitochondrial and independent of FADD/caspase-8, while the extrinsic pathway is triggered by death receptors and requires FADD/caspase-8.
Can negative regulation of hypoxia-induced apoptosis be targeted therapeutically?
Yes, in cancer, inhibiting negative regulators can promote apoptosis; in ischemia, enhancing them may protect tissues.
What CRISPR screening services does EDITGENE offer for this pathway?
EDITGENE offers genome-wide CRISPR knockout screens, custom library screening, and bioinformatics analysis to identify regulators of hypoxia-induced intrinsic apoptosis.
Conclusion
GO:1903298, negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway, is a critical biological process that governs cell survival under low oxygen conditions. The pathway is intimately linked to mitochondrial dynamics and BCL-2 family regulation, with significant implications for cancer, ischemia, and neurodegeneration. Leveraging CRISPR-based models and functional genomics, researchers can dissect the molecular players and develop targeted therapies. EDITGENE provides the necessary tools and expertise to accelerate discoveries in this field.
References
- 1. Weinmann M et al.. 2004. Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner.. Oncogene 23(21):3757-69 PMID: 15034549
